Ignite Creation Date:
2024-05-05 @ 5:22 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00446849
Status:
COMPLETED
Last Update Posted:
2021-06-14
First Post:
2007-03-12
Brief Title:
Strategies in Maintenance for Patients Receiving Long-term Therapy SIMPLE With MMX Multi-Matrix System Mesalamine for Ulcerative Colitis UC
Sponsor:
Shire
Organization:
Takeda
Study Overview
Official Title:
A Phase IV Multi-center Open-label Study to Assess Clinical Recurrence Related to Compliance With Treatment With MMX Mesalamine 24gDay Given Once Daily for the Maintenance of Quiescent Ulcerative Colitis UC
Status:
COMPLETED
Status Verified Date:
2021-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate the percentage of subjects with clinical recurrence of UC at 6 months using MMX mesalamine once daily
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None